HomeHEMO • LON
add
Hemogenyx Pharmaceuticals PLC
Previous close
GBX 178.00
Day range
GBX 173.41 - GBX 180.50
Year range
GBX 160.00 - GBX 1,199.96
Market cap
7.53M GBP
Avg Volume
29.32K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.34M | 19.40% |
Net income | -1.40M | -18.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.29M | -20.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 159.26K | -87.23% |
Total assets | 4.21M | -31.02% |
Total liabilities | 3.36M | 1.00% |
Total equity | 853.49K | — |
Shares outstanding | 3.50M | — |
Price to book | 6.85 | — |
Return on assets | -79.72% | — |
Return on capital | -96.57% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.40M | -18.43% |
Cash from operations | -894.62K | 30.19% |
Cash from investing | -9.53K | 74.06% |
Cash from financing | 117.42K | -72.36% |
Net change in cash | -741.75K | 19.25% |
Free cash flow | -555.78K | -3.09% |
About
Founded
2013
Website
Employees
16
